Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs). [electronic resource]
Producer: 20140324Description: 854-63 p. digitalISSN:- 1876-7605
- Acute Coronary Syndrome -- blood
- Aged
- Aged, 80 and over
- Area Under Curve
- Biomarkers -- blood
- Cell Adhesion Molecules -- blood
- Clopidogrel
- Coronary Thrombosis -- blood
- Drug Resistance
- Female
- Hemorrhage -- blood
- Humans
- Logistic Models
- Male
- Microfilament Proteins -- blood
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Phosphoproteins -- blood
- Phosphorylation
- Piperazines -- adverse effects
- Platelet Activation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests
- Prasugrel Hydrochloride
- Prospective Studies
- ROC Curve
- Risk Assessment
- Risk Factors
- Thiophenes -- adverse effects
- Ticlopidine -- adverse effects
- Time Factors
- Treatment Outcome
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.